Dr. Gish answered answered a number of very important questions for those diagnosed with liver cancer, and also has some great advice for liver cancer surveillance, including best imaging tests for the diagnosis of cirrhosis or liver cancer and more. Continue reading "Q & A – Treatment Options for Liver Cancer Webinar"
In celebration of Asian Pacific Heritage Month, Dr. moon Chen, Principal Investigator for the Asian American Network for Cancer Awareness Research and Training (AANCART) and UC Davis professor, reflects on the unnecessary cancer burden in Asian American and Pacific Islanders, including the burden of hepatitis B related liver cancer. Continue reading "May is Asian Pacific American Heritage Month"
Myth: Clinical trials are only for people with advanced stages of cancer.
Fact: No! Trials are available for all stages of cancer, not just for people who have advanced cancer that is not responding to treatment.
If you or a loved one needs treatment for liver cancer, clinical trials are an option to think about. Continue reading "Clinical Trials in Liver Cancer: What You Need to Know"
Hoping to learn more about treatment options for liver cancer, but weren’t able to make the webinar with Dr. Gish on April 27th? Continue reading "Treatment Options for Liver Cancer YouTube Webinar With Dr. Robert Gish"
Please join the Hepatitis B Foundation’s Liver Cancer Connect program and world-renowned liver disease specialist, Dr. Robert Gish for a webinar on Monday, April 27th 12 noon EDT to learn about liver cancer treatment. How does the stage of the cancer affect treatment? Why are screening and surveillance so important? What are the available treatments and what are the therapies in development? Continue reading "Webinar on Treatment Options for Liver Cancer: What You Need to Know"
February 28 is Rare Disease Day.
Last year, we featured the story of Gail Trecosta, who described how her teenage son Matthew was bravely battling a rare form of liver cancer called fibrolamellar hepatocellular carcinoma (FHC).
This year we are featuring FHC again but with a renewed sense of urgency and purpose. Continue reading "Slaying the Fibrolamellar Beast"
According to media headlines, a recent study apparently found that cancers are mainly caused by “bad luck.” But are the headlines accurate? And if so, do we just cross our fingers and hope for the best? Continue reading "Not Just Bad Luck"
Get HBV Advocate’s Christine Kukka’s take on the top HBV related, published reports from the AASLD Liver Meeting as she provides her Top Ten List!
Top Ten Reports from the 65th Annual Liver Meeting
By Christine M. Kukka, HBV Advocate
Hepatitis B experts from around the world met at the 65th annual American Association for the Study of Liver Diseases (AASLD) conference in Washington D.C. this week to share the latest in hepatitis B treatment and research.
Continue reading "AASLD 2014 Liver Meeting – HBV Coverage"
In recognition of Liver Cancer Awareness Month, Liver Cancer Connect is highlighting some of the advances in prevention, screening, and treatment that are leading to increased survival among people with liver cancer. Continue reading "Fighting the Doom and Gloom: Prevention Works!"
Recent projections for the top cancer killers in 2030 confirmed some encouraging trends but also sounded a warning bell. Continue reading "It’s Time to Take On the Deadliest Cancers"
